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To the editor:  34 
Longitudinal melanonychia (LM) is the presenting sin of nail unit melanoma (NUM) in 2/3 35 
of cases and is therefore among the most important conditions managed by dermatologists. In 36 
normal times, referral for LM would prompt an expedit  appointment for clinical 37 
examination and dermoscopy.1 However, due to SARS-CoV-2, dermatologists have been 38 
asked to reconsider “urgent/emergency” conditions. The COVID-19 pandemic has propelled 39 
physicians to unexpectedly adopt telemedicine withou  adequate guidance for managing LM 40 
patients. 41 
General nail telemedicine guidelines are listed in Table 1, which may be used to narrow the 42 
differential diagnosis of a patient presenting with LM (Table 2). We recommend tele-43 
examination in an area with excellent lighting, and examining each nail unit individually, 44 
with palmar and plantar surfaces. A thorough clinical examination is performed on the 45 
relevant nail unit(s), with measurement of band width, igit involved, band color, band 46 
borders, nail splitting, bleeding, ulceration and presence of pigment on the nail folds or 47 
hyponychium. Patient photos sent prior to the telemdicine appointment are often superior to 48 
“live” video images.  Patients may to be coached to ph tograph their nails in focus, using a 49 
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solid backdrop to frame the nail and direct camera focus. 50 
 In cases suspicious for NUM, or when telemedicine a d supplementary photography 51 
preclude a benign diagnosis, an in-office visit is recommended, after screening the patient for 52 
COVID-19 symptoms and exposure. Necessary precautions are taken, including virtual check 53 
in/check out, the patient coming alone and wearing a mask, social distancing and staff 54 
wearing appropriate personal protective equipment. Si ce contact dermoscopy is preferred 55 
for evaluation of LM,2 disposable caps are used and then discarded. Alternatively, indirect 56 
dermoscopy will minimize direct patient contact. 57 
 If a biopsy is warranted to rule out NUM, an N95 mask and face shield is suggested 58 
for the dermatologist and medial assistant, since there is close prolonged contact with the 59 
patient during preparation, anesthesia, biopsy, dressing application, and patient education. 60 
While a cooling device and/or vibration may be used to mitigate pain during digital 61 
anesthesia, talkesthesia, a disposable stress ball and ethyl chloride spray are preferred to 62 
avoid cross contamination. Firm pressure, aluminium chloride, and other hemostatic 63 
techniques are favored over cautery to prevent viral spread.3 Disposable sutures (rapidly 64 
absorbable polyglactin 910) are used to circumvent pos -operative visits, with written 65 
instructions given, and follow-ups facilitated by telemedicine.  66 
NUM requires prompt treatment, despite recent guidelines from the National Comprehensive 67 
Cancer Network recommending delayed excision for in situ and T1 melanomas for up to 3 68 
months (https://www.nccn.org/covid-19/pdf/Melanoma.pdf). NUMs are often diagnosed in 69 
later stages than cutaneous melanomas, with 5- and 10-year survival rates 30% and 13%, 70 
respectively, for NUM. An en bloc (wide local) excision is performed in the office setting for 71 
NUM in situ and recommended over digit amputation to preserve functionality without 72 
increased mortality.4,5  73 
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Telemedicine can be optimized for diagnosis and treatm nt for many cases of LM while 74 
COVID-19 is prevalent. LM concerning for NUM necessitates prompt diagnosis with biopsy 75 
and histopathology; NUM requires timely excision to decrease morbidity and mortality. 76 
Abbreviations: 77 
LM – longitudinal melanonychia 78 
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Table 1: General nail telemedicine guidelines 98 
Perform the examination in an area with excellent lighting, preferably natural light.  
This examination should include all 20 nails, with particular attention paid to presence of 
number of nails involved.  Each nail unit is ezamined individually, with palmar and plantar 
surfaces.  
A thorough clinical examination is performed on therelevant nail unit(s). If the telemedicine 
platform is equipped with a ruler: the width of the band and entire nail plate are measured. 
Alternatively, the patient is guided to use a ruler and the dermatologist measures the band and 
nail plate width in real time.  
In addition to band width, digit involved (one, several, all, and type of digit), band color, 
band borders, nail splitting, bleeding, ulceration and presence of pigment on the nail folds or 
hyponychium is noted.  
 99 
Table 2: Etiologies of longitudinal melanonychia, clini al features, telemedicine pearls, and 100 
treatments 101 
Diagnosis Clinical Features Telemedicine 
Pearls/Treatment 
Exogenous pigment Brown-black dark linear 
longitudinal bands on the 
nail plate, with irregular 
medial border. The 
Ask patient to clean with 
70% alcohol or acetone. 
For exogenous pigment, 
the pigment will wipe 
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pigment may not be 
linear. 
Examples: dirt, tar, 
newspaper print, tobacco, 
cloth and hair dyes, 
henna 
off. 
Subungual hematoma Purple to brown-black 
amorphous areas; 
elliptical bandlike areas. 
Leukonychia may overlie 
the pigmented area. The 
pigment is often not 
linear. Onycholysis is 
often present. 
 
Ask patient to take serial 
photos monthly. Explain 
average nail growth rates: 
2-3mm/month for 
fingernails and 1 
mm/month for toenails. 
The pigment will grow 





Linear brown-black or 
greenish pigmentation 
seen though the nail 
plate. 
Recommend keeping 
nails short and dry. Trim 
back all onycholytic nail.  
Consider trial of 
gentamicin 0.03% 
solution or hypochlorite 
sodium nightly for three 
months. 
Fungal melanonychia The pigmented band is 
narrower proximally and 
Look for involvement of 
more than one nail, scale 
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wider distally, with 
pointed extensions 
proximally. Note that 
these intricacies may be 
difficult to appreciate 
with telemedicine. 
on the subungual area 
and on the plantar feet 
and web spaces. 
Recommend topical 
antifungal to treat tinea 
pedis. Patient will need 
an in-person visit when 




Melanocytic activation Homogenous grey-brown 
band(s) that is typically 
present on more than one 
nail (1st, 2nd, 3rd 
fingernails most common 
involvement of the 
bilateral 4th and 5th 
toenails is also common). 
Assess phototype, obtain 
medication list, and 
medical history. 
Involvement of more 
than one nail makes a 
benign etiology most 
likely. Ask patient to take 
serial photos monthly. 
Atypia of band, widening 
or darkening of one band, 
pain, splitting, bleeding, 
or ulceration necessitates 
an in-person visit and 
probable biopsy to rule 
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out nail unit melanoma. 
Nail unit nevus Brown-black longitudinal 
band involving one nail 
unit, typically first 
presenting in a child. 
Nail unit melanomas are 
exceedingly rare in white 
children. If stable, the 
patient should be seen in-
office when reasonable 
for clinical examination 
and dermoscopy. Rapid 
growth, darkening, pain, 
or onychodystrophy 
necessitates a prompt in-
office visit. 
Nail unit melanoma Brown-black longitudinal 
band involving a single 
digit. Thumb and hallux 
most common. Width > 
3mm and/or >40% of 
total nail plate width, 
splitting, bleeding, 
ulceration are concerning 
for NUM. 
Any of these clinical 
features necessitates an 
in-person examination 
with clinical 
examination, 
dermoscopy, and 
photography with 
probable biopsy. 
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